About ITM
ITM is a privately owned biotechnology and radiopharmaceutical group of companies dedicated to the development, production and global supply of targeted diagnostic and therapeutic radiopharmaceuticals and radioisotopes for use in cancer...
Regulatory Affairs Manager (gn) Design Control
Formycon is an international leading, independent developer of high-quality biopharmaceutical medicines, especially biosimilars. With an experienced team comprised of around 240 highly skilled profess...
CatalYm GmbH is a clinical-stage biotechnology company dedicated to advancing cancer treatment through pioneering Visugromab, a recombinant antibody targeting the immunosuppressive cytokine GDF-15. Under physiological conditions, GDF-15 is essential...
Head of Regulatory Affairs CMC Drug Product (gn)
Manager First Level
Medicine, Pharmacy, Laboratory
Quality Management, Quality Assurance
Formycon is an international leading, independent developer of high-quality biopharmaceutical medicin...
About ITM
ITM is a privately owned biotechnology and radiopharmaceutical group of companies dedicated to the development, production and global supply of targeted diagnostic and therapeutic radiopharmaceuticals and radioisotopes for use in cancer ...
(Senior) Research Associate - Immuno-Oncology (gn)
About us
iOmx Therapeutics is a clinical-stage company in the field of immuno-oncology located in Martinsried/Munich, Germany. We are focusing on the development of first-in-class cancer immunot...
(Senior) Research Associate - Immuno-Oncology (gn)
About us
iOmx Therapeutics is a clinical-stage company in the field of immuno-oncology located in Martinsried/Munich, Germany. We are focusing on the development of first-in-class cancer immunot...
About ITM
ITM is a privately owned biotechnology and radiopharmaceutical group of companies dedicated to the development, production and global supply of targeted diagnostic and therapeutic radiopharmaceuticals and radioisotopes for use in cancer ...
Regulatory Affairs Manager (gn) Design Control
Formycon is an international leading, independent developer of high-quality biopharmaceutical medicines, especially biosimilars. With an experienced team comprised of around 240 highly skilled profess...
CatalYm GmbH is a clinical-stage biotechnology company dedicated to advancing cancer treatment through pioneering Visugromab, a recombinant antibody targeting the immunosuppressive cytokine GDF-15. Under physiological conditions, GDF-15 is essential...
